The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
AimsTo compare the efficacy and safety of new insulin glargine 300 U/ml (Gla‐300) with that of glargine 100 U/ml (Gla‐100) in insulin‐naïve people with type 2 diabetes using oral glucose‐lowering drugs.
MethodsThe EDITION 3 study was a multicentre, open‐label, parallel‐group study. Participants were randomized to Gla‐300 or Gla‐100 once daily for 6 months, discontinuing sulphonylureas and glinides,...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.